CryoCell International Inc Total Liabilities
CryoCell International Inc total liabilities. Based on the latest financial reports, CryoCell International Inc (CCEL) has total liabilities worth $78.00 Million USD as of August 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See CryoCell International Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Total Liabilities of CryoCell International Inc (1996–2024)
Total liabilities of CryoCell International Inc from 1996 to 2024. This chart illustrates how CryoCell International Inc's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are CryoCell International Inc's assets to evaluate the company's liquid asset resilience ratio.
CryoCell International Inc Competitors by Total Liabilities
The table below lists competitors of CryoCell International Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zoomd Technologies Ltd
V:ZOMD
|
Canada | CA$7.98 Million |
|
Century Lithium Corp.
V:LCE
|
Canada | CA$184.90K |
|
Panagene Inc
KQ:046210
|
Korea | ₩24.65 Billion |
|
Hudson Acquisition I Corp. Common Stock
NASDAQ:HUDA
|
USA | $7.47 Million |
|
Midland Exploration Inc
V:MD
|
Canada | CA$1.87 Million |
|
Kriti Industries (India) Limited
NSE:KRITI
|
India | Rs2.61 Billion |
|
Siab Holdings Bhd
KLSE:0241
|
Malaysia | RM547.51 Million |
|
PolTREG S.A.
WAR:PTG
|
Poland | zł30.71 Million |
Liability Composition Analysis (1996–2024)
This chart breaks down CryoCell International Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see CCEL asset base.
Liquidity & Leverage Metrics
CryoCell International Inc Total Liabilities Ratios Explained
CryoCell International Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.63 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -5.26 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CryoCell International Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CryoCell International Inc (1996–2024)
The table below shows the annual total liabilities of CryoCell International Inc from 1996 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-11-30 | $77.89 Million | +7.81% |
| 2023-11-30 | $72.25 Million | +8.79% |
| 2022-11-30 | $66.41 Million | +17.59% |
| 2021-11-30 | $56.48 Million | +15.58% |
| 2020-11-30 | $48.87 Million | -1.95% |
| 2019-11-30 | $49.84 Million | -2.84% |
| 2018-11-30 | $51.30 Million | +40.88% |
| 2017-11-30 | $36.41 Million | +4.18% |
| 2016-11-30 | $34.95 Million | +42.89% |
| 2015-11-30 | $24.46 Million | +16.84% |
| 2014-11-30 | $20.94 Million | +0.81% |
| 2013-11-30 | $20.77 Million | -2.62% |
| 2012-11-30 | $21.33 Million | -2.73% |
| 2011-11-30 | $21.93 Million | +11.23% |
| 2010-11-30 | $19.71 Million | -0.38% |
| 2009-11-30 | $19.79 Million | +10.24% |
| 2008-11-30 | $17.95 Million | -1.50% |
| 2007-11-30 | $18.22 Million | +8.92% |
| 2006-11-30 | $16.73 Million | +20.91% |
| 2005-11-30 | $13.84 Million | +10.92% |
| 2004-11-30 | $12.48 Million | +13.34% |
| 2003-11-30 | $11.01 Million | +175.50% |
| 2002-11-30 | $4.00 Million | +39.07% |
| 2001-11-30 | $2.87 Million | +79.37% |
| 2000-11-30 | $1.60 Million | +220.35% |
| 1999-11-30 | $500.00K | -72.22% |
| 1998-11-30 | $1.80 Million | +100.00% |
| 1997-11-30 | $900.00K | +80.00% |
| 1996-11-30 | $500.00K | -- |
About CryoCell International Inc
Cryo-Cell International, Inc. engages in cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells, which are used in regenerative medicine to treat a range of conditions. The company manu… Read more